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Available online 14 March 2008Vertebrate retinal progenitor cells (RPCs) undergo a robust proliferative expansion to produce enough cells
for the retina to form appropriately. Vsx2 (formerly Chx10), a homeodomain protein expressed in RPCs, is
required for sufﬁcient proliferation to occur. Sonic Hedgehog protein (SHH), secreted by retinal ganglion
cells (RGCs), activates Hedgehog (Hh) signaling in RPCs and is also required for sufﬁcient proliferation to
occur. Therefore, we sought to determine if reduced Hh signaling is a contributing factor to the
proliferation changes that occur in the absence of Vsx2. To do this, we examined Shh expression and Hh
signaling activity in the homozygous ocular retardation J (orJ) mouse, which harbors a recessive null allele
in the Vsx2 gene. We found that Shh expression and Hh signaling activity are delayed during early retinal
development in orJ mice and this correlates with a delay in the onset of RGC differentiation. At birth,
reduced expression of genes regulated by Hh signaling was observed despite the production of SHH ligand.
orJ RPCs respond to pre-processed recombinant SHH ligand (SHH-N) in explant culture as evidenced by
increased proliferation and expression of Hh target genes. Interestingly, proliferation in the orJ retina is
further inhibited by cyclopamine, an antagonist of Hh signaling. Our results suggest that reduced Hh
signaling contributes to the reduced level of RPC proliferation in the orJ retina, thereby revealing a role for
Vsx2 in mediating mitogen signaling.











Mammalian retinal progenitor cells (RPCs) undergo multiple
rounds of proliferative cell division to generate the millions of cells
necessary to comprise a typical retina. In mice, RPC proliferation
begins at embryonic day 10 (E10) and lasts 3 weeks, until post-natal
day 10 (P10; all times approximate). From the beginning of this period,
some of the generated cells exit the cell cycle and differentiate (Young,
1985), producing all seven major retinal cell classes in a highly speciﬁc
and sequential, but overlapping, order (Livesey and Cepko, 2001).
Therefore, RPC proliferation is crucial not only for generating the
necessary number of cells, but also for ensuring sufﬁcient progenitors
are available for the production of all retinal cell types. Disruptions of
this process in either direction can lead to alterations in retinal
structure and function, with severe disruptions resulting in micro-
phthalmia or retinoblastoma. Thus, normal retinal development
requires precise regulation of RPC proliferation (reviewed in Donovan
and Dyer, 2005; Levine and Green, 2004).N.Medical Drive, Salt Lake City,
l rights reserved.Proliferation in the retina, as in other tissues, is a process inﬂuenced
by a number of intrinsic and extrinsic factors. Homeodomain and cell
cycle proteins are cell-intrinsic factors necessary for proper RPC
proliferation (reviewed in Del Bene and Wittbrodt, 2005; Levine and
Green, 2004). Additionally, cell-extrinsic factors, such as mitogens, are
also important in promoting RPC proliferation (reviewed in Dakubo
and Wallace, 2004; Yang, 2004). However, little is known regarding if
and how these different factors coordinate their activities to drive RPC
proliferation during retinal development.
The Vsx2 gene (formerly Chx10; Mouse Genome Database (URL:
http://www.informatics.jax.org)) encodes a homeodomain-contain-
ing transcription factor that is expressed by RPCs from the
beginning of retinal development, during optic cup formation.
RPCs continue to express Vsx2 throughout their proliferative period,
but as they differentiate, Vsx2 expression is lost in all postmitotic
retinal cell types, except bipolar interneurons and a subset of Muller
glia. Mice and humans with mutations in Vsx2/VSX2 exhibit
microphthalmia, or small eyes, a condition resulting in part from a
profound defect in RPC proliferation that leads to a severe reduction
in retinal cell number (Bar-Yosef et al., 2004; Bone-Larson et al.,
2000; Burmeister et al., 1996; Dhomen et al., 2006; Ferda Percin et
al., 2000; Green et al., 2003; Konyukhov and Sazhina, 1971; Livne-
Bar et al., 2006). Interestingly, Vsx2 apparently utilizes multiple
561C.L. Sigulinsky et al. / Developmental Biology 317 (2008) 560–575mechanisms to control RPC proliferation. For example, Vsx2
regulates cell cycle progression by preventing accumulation of the
cyclin-dependent kinase inhibitor protein p27Kip1 via a CyclinD1-
dependent mechanism (Ccnd1; formerly referred to as CycD1)
(Green et al., 2003). Vsx2 also prevents expression of the
transcription factor Mitf. Mitf expression in orJ RPCs biases them
towards a pigmented cell fate, which appears to include a more
restricted proliferative expansion (Horsford et al., 2005; Rowan et
al., 2004). Later in retinal development, Vsx2 has additional roles in
specifying neural cell fate: inhibiting rod photoreceptor generation,
and promoting bipolar cell generation (Belecky-Adams et al., 1997;
Dorval et al., 2006; Hatakeyama et al., 2001; Livne-Bar et al., 2006;
Rowan and Cepko, 2004; Rutherford et al., 2004; Toy et al., 2002).
However, these roles appear to be largely independent of its roles in
promoting proliferation (Green et al., 2003; Livne-Bar et al., 2006).
Despite these advances in understanding the roles of Vsx2 in retinal
development, the full extent of its activity is not yet known.
Sonic Hedgehog (Shh) is a member of the Hedgehog (Hh) family
of genes encoding secreted signaling molecules. Like other Hh
family members (Indian Hedgehog (IHH) and Desert Hedgehog
(DHH) in mammals), SHH activates the Hh signaling network
(Cohen, 2003; Ingham and McMahon, 2001; Nybakken and Perrimon,
2002; Varjosalo and Taipale, 2007). Binding of Hh ligand to the
transmembrane receptor, Patched homolog 1 (Ptc1), relieves Ptc1-
mediated inhibition of Smoothened (Smo) activity, leading to acti-
vation of the Gli family of transcriptional regulators, which ultimately
alters gene expression in the target cell. Transcriptional targets of the
Hh signaling pathway (referred to hereafter as Hh target genes)
include both positive and negative regulators of the Hh signaling
network, cell cycle regulators, extrinsic signaling molecules, cell
speciﬁcation and differentiation genes (Ho and Scott, 2002; Oliver et
al., 2003). Transcription of these target genes is often context-
dependent, which is not surprising given the diverse roles attributed
to Hh signaling (Cohen, 2003; Ingham and McMahon, 2001).
SHH is both a well-established and well-characterized retinal
mitogen. In the mouse retina, production and secretion of SHH by
retinal ganglion cells (RGCs) closely follows the central-to-periph-
eral wave of RGC differentiation (Wang et al., 2005; Dakubo et al.,
2003), which begins around E11.5. RGC-derived SHH activates Hh
signaling in adjacent RPCs, as evidenced by changes in Hh target
gene expression (Wang et al., 2005). Active Hh signaling in the
murine retina overlaps the principal period of proliferative expan-
sion and is both necessary and sufﬁcient for RPC proliferation.
Treatment with recombinant, pre-processed SHH protein (SHH-N)
(Jensen and Wallace, 1997; Levine et al., 1997) or constitutive
activation of Hh signaling (Moshiri and Reh, 2004) increases murine
RPC proliferation, while conditional ablation of Shh (Wang et al.,
2005, 2002) or treatment with anti-SHH antibodies (Wallace and
Raff, 1999) decreases proliferation. Recent work in Xenopus and
zebraﬁsh suggests that the effects of SHH on proliferation are
accomplished by acceleration of the G1 and G2 phases of the cell
cycle (Locker et al., 2006).
In addition to the fact that both Vsx2 and Shh are critical regulators
of RPC proliferation, Shh conditional knockout mice exhibit ocular
phenotypes similar to orJmice, including disrupted retinal lamination
and microphthalmia (Dakubo et al., 2003; Wang et al., 2002). In this
study, we investigated whether other facets of proliferative control
mediated by Vsx2 involve Hh signaling.
Methods
Nomenclature
Many commonly used gene names and symbols are changing to conform to
nomenclature rules implemented by the Mouse Genome Nomenclature Committee and
HUGO Gene Nomenclature Committee. Relevant to this study are: Vsx2 for Chx10;
Pou4f2 for Brn3b; Ccnd1 for Cyclin D1/CycD1.Animals
orJ mice were obtained from Jackson labs (Bar Harbor, ME). The orJ and + (wild
type) alleles were determined by PCR and restriction digests with mouse tail DNA
(Burmeister et al., 1996). All mice were on a 129/Sv background. Animals were housed
and cared for according to IACUC guidelines. Previous work ((Rowan and Cepko,
2004) and our unpublished observations) suggests that eye development in
heterozygous orJ (orJ/+) mice is phenotypically indistinguishable from that in wild
type (+/+) mice. Therefore, mice with these genotypes were considered equivalent
and are referred to hereafter as wild type. Homozygous orJ (orJ/orJ) mice are referred
to as orJ.
In situ hybridization
After dissection in Hank's buffered saline solution (HBSS), embryonic heads and P0
eyes were ﬁxed overnight at 4 °C with 4% paraformaldehyde (PFA) in phosphate-
buffered saline (PBS, pH 7.5) or 4% formaldehyde in PBS/2 mM EGTA, followed by
cryoprotection and storage at −80 °C. Sections (12 μm) were cut and stored at −20 °C
until use. In situ hybridization was performed as previously described (Green et al.,
2003; Schaeren-Wiemers and Gerﬁn-Moser, 1993). Probes used in this study were
digoxigenin-labeled anti-sense probes against Shh, Gli1, Ptc1, Ptc2, Hedgehog interacting
protein (Hhip), and Vsx2.
Immunohistochemistry
After dissection in HBSS, embryonic head or retinal tissue was ﬁxed in 4% PFA in
PBS for 1 to 3 h at room temperature or overnight at 4 °C. Tissue ﬁxation was
followed by cryoprotection and storage at −80 °C until sectioning. Sections (10 μm for
E12.5 cultured retinal explants and 12 μm for all other samples) were cut and stored
at −20 °C until use.
Sections were pre-treated for 30 min in block buffer (2% normal goat or donkey
serum, 0.15% TritonX-100, and 0.01% sodium azide in PBS). Sections were then
labeled with primary antibodies diluted in block buffer. The primary antibodies used
in this study include rabbit anti-acetylated Class III beta-Tubulin (acTUBB3; Tuj1
antibody; Covance, Richmond, CA); rat anti-bromodeoxyuridine (BrdU; clone ICR1;
Accurate Chemical and Scientiﬁc Corporation, New York, NY); goat anti-POU4F2
(Brn3b antibody; Santa Cruz Biotechnology, Santa Cruz, CA); rabbit anti-phosphory-
lated Histone H3 (pHH3; Upstate Biotechnology, Lake Placid, NY), mouse anti-PCNA
(clone PC10; Dako, Carpinteria, CA) and rabbit anti-SHH (Santa Cruz Biotechnology,
Santa Cruz, CA). Hydrochloric acid treatment (2N HCl; 1 h at room temperature) was
performed prior to incubation with the BrdU antibody. Antigen unmasking (0.18 mM
Citric Acid, 77 μM Sodium Citrate, ﬁnal working concentrations, pH 6.0, 15 min at 90–
95 °C) was performed prior to incubation with the PCNA antibody. Sections were
then labeled with species-speciﬁc secondary antibodies conjugated to Alexaﬂuor 488
or 568 (Invitrogen, Carlsbad, CA). Nuclei were stained with 4,6-diamidino-2-
phenylindole (DAPI; Fluka, Switzerland), and slides were mounted with glass
coverslips for microscopy.
When immunohistochemistry was performed after in situ hybridization on the
same sections, pre-treatment with block buffer was omitted and antibodies were
diluted in in situ buffer B1 (0.1 M Tris, pH 7.5, 0.15 M NaCl) plus 1% goat serum. In situ
buffer B1 was used in place of PBS for rinse steps.
Semi-quantitative RT-PCR (sqRT-PCR) and analysis
Dissected retinal tissue was rapidly frozen by submersion into liquid nitrogen
and stored at −80 °C until use. Total RNA was isolated using the RNeasy® Mini or
RNeasy® Micro Spin Protocol for isolation of total RNA from animal cells (Qiagen,
Valencia, CA). cDNA for use in RT-PCR was synthesized from 100 ng total RNA using
the ReactionReady First Strand cDNA Synthesis kit (SuperArray Bioscience Corpora-
tion, Frederick, MD). Analysis of relative gene expression was performed according to
the RT2 End-Point PCR Assay Protocol using RT2 PCR Primer Sets for each gene of
interest (SuperArray Bioscience Corporation, Frederick, MD). The PCR conditions for
all genes were as follows: preheat, 95 °C for 15 min; cycling, 95 °C for 30 s followed
by 55 °C for 30 s and 72 °C for 30 s. The number of PCR cycles for each gene were as
follows: 25 cycles, beta-Actin (Actb); 30 cycles, Ccnd1, Gli3, and Smo; 33 cycles,
Pou4f2, Gli1, Gli2, Hhip, Ptc1, Ptc2, and Shh. Cycle number was determined based on
optimization curves generated for each primer set (Supplemental Fig. S1). Actb
served as a control for RNA input for each sample run. Gels were analyzed using
ImageJ software (NIH). Three to seven samples (pooled or unpooled) were analyzed.
Student's unpaired t-test or Welch's Two Sample t-test were performed to determine
statistical signiﬁcance as appropriate (based on results of the F-test of Variances).
Western blots
Sample preparation and western blots were performed as previously described
(Clark et al., 2008). Primary antibodies used included: rabbit anti-SHH; mouse anti-
ACTB (Chemicon, Temecula, CA); mouse anti-CCND1 (Santa Cruz Biotechnology).
Enhanced chemiluminescent detection of horseradish peroxidase was performed using
SuperSignal West Dura (Pierce Biotechnology, Rockford, IL), and captured using a
562 C.L. Sigulinsky et al. / Developmental Biology 317 (2008) 560–575ChemiDoc XRS imaging system (Bio-Rad, Hercules, CA). Speciﬁcity controls for SHH
immunoreactivity are presented in Supplemental Fig. S2.
Retinal explant cultures
Whole retinal tissuewith the lens and vitreal chamber intactwas dissected away from
surrounding tissues in HBSS and placed into cell culture plates. For P0 samples, retinal
explants were cultured in 24-well cell culture plates containing 1–2ml of culturemedium
(DMEM/F12; Invitrogen), 0.6% glucose, 0.1125% NaHCO3, 5 mM Hepes, 1% FBS, 1.5 μM
thymidine, Glutamax (0.5×, Invitrogen), 25 μg/ml insulin (Sigma, St. Louis, MO), 100 μg/ml
transferrin (Sigma), 60 μM putrescine (Sigma), 30 nM selenium (Sigma), 20 nM
progesterone (Sigma), and Penicillin/Streptomycin (1×, Invitrogen). E12.5 retinal explants
were cultured in 48-well cell culture plates containing 450 μl of culture medium.
To test the effects of SHH treatment, one explant from eachmousewas cultured in the
absence of SHH-N, while the explant from the contralateral eye was cultured in the
presence of 108 ng/ml SHH-N (Levine et al.,1997). Cultureswere incubated at 37 °C and 5%
CO2, with nutating to ensure good perfusion of solutions throughout the retina. For
proliferation assays, explants were cultured for 24 h, with BrdU present at a ﬁnal
concentration of 10 μg/ml for the last 2 h for P0 samples and 30min for the E12.5 samples.
Explants from a minimum of 4 mice were analyzed for each age, genotype and condition.Fig. 1. Expression patterns of Hh target genes at E12.5. Gli1 (A, B), Ptc1 (C, D) and Hhip (E, F)
and (E) demarcate Gli1 and Hhip expression in the dorsal retina, while closed arrowheads ind
as a control. Open arrowheads in (H) indicate reduced expression of Vsx2 in the extreme peri
extra-ocular mesenchyme; L, lens; NR, neural retina; RPE, retinal pigmented epithelium; DFor western blots, a minimum of three explants from separate mice were cultured for 8 h.
At the endof the culture period, lens and vascular tissueswere removedanddiscarded. The
isolated retinas were pooled according to genotype and condition prior to protein
extraction. For gene expression measurements by sqRT-PCR, explants were cultured for
8 h. Lens and vascular tissues were separated from retinal tissue prior to RNA isolation.
Explants from at least four mice were analyzed for each genotype and condition.
To test the effects of cyclopamine, one explant per mouse was cultured with 0.41%
(v/v) DMSO added to the media as a vehicle control, while the explant from the
contralateral eye was cultured in the presence of 10 μM cyclopamine (Toronto Research
Chemicals, North York, Ontario) in 0.41% (v/v) DMSO. For in situ analyses, explants were
cultured for 16 h. For proliferation analyses, explants were cultured for 24 h with BrdU
present at a ﬁnal concentration of 10 μg/ml for the last 2 h. Explants from aminimum of
four mice were analyzed for each condition.
Marker quantiﬁcation and statistical analyses
Quantiﬁcation of BrdU+, pHH3+, and PCNA+ cells was accomplished by direct counting
in retinal sections. For wild type samples, images of the regions between the central and
peripheral domains were analyzed. For orJ samples, the entire retinal cross section was
analyzed. Images for BrdU and PCNA were collected on an Olympus Fluoview 1000mRNA expression was detected in wild type retinas, but not in orJ retinas. Arrows in (A)
icate areas of signal outside the retina. In situ hybridization for Vsx2mRNA (G, H) serves
phery of orJ retinas. Ventral is to the left in all panels. Scale bar: 200 μm. C, cornea; EOM,
, dorsal; V, ventral.
563C.L. Sigulinsky et al. / Developmental Biology 317 (2008) 560–575confocal microscope. Images for pHH3 were collected on a Nikon E600 epiﬂuorescence
microscope. Cell counts were done in Photoshop (Adobe) and Image J (NIH). Retinal area
was calculated by determining the pixel area using ImageJ and converting to area inmm2.
The apical/ventricular surface distance was calculated by determining the length of this
surface in pixels using ImageJ and converting to length in mm. Multiple regions countedFig. 2. Expression patterns of Shh and Hh target genes at E15.5. ShhmRNA (A, B) expression e
orJ retinas. Areas of retinal expression indicated with arrows. Gli1 (C) and Ptc1 (E) transcrip
retina. However, their expression in the orJ retina (D, F) was centrally restricted. Hhip mR
hybridization for Vsx2 mRNA (I, J) serves as a control. Open arrowheads in (J) indicate regi
expression is an artifact due to tissue folding. Ventral is to the left in all panels. Scale bar: 2from the same retinal sectionwere summed while multiple regions from the same retina
but different sections were averaged. Student's paired t-test was performed to determine
the statistical signiﬁcance of the effects of SHH-Nor cylopamine treatment betweenpaired
samples of each genotype. Tabulated cell counts for the P0 explant experiments are shown
in Supplemental Tables 1–3.xtends to the peripheral retina in wild type eyes, but is restricted to the central region in
ts were also detected in wild type retinas, with expression extending to the peripheral
NA expression was detected in wild type retinas (G), but not in orJ retinas (H). In situ
ons of presumptive transdifferentiated retina. Asterisk in (J) indicates that lack of Vsx2
00 μm.
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Altered Hh signaling during embryonic stages in the orJ retina coincides
with a delay in Shh expression
To determine whether Vsx2 is necessary for Hh signaling in the
developing embryonic retina, we compared the spatial and temporalFig. 3. Hh signaling activity correlates with RGC differentiation in both wild type and
reactivity and Gli1 mRNA expression, respectively. (A–C) In E15.5 wild type retinas, bo
(D–F) In E15.5 orJ retinas, both acTUBB3 signal and Gli1 expression are more centrally
not located in the retinal neuroepithelium. (G–I) Patterns of acTUBB3 and Gli1 in E12.5 w
retina correlates well with acTUBB3 staining, indicating that many of the acTUBB3-posit
100 μm for (J–L).expression patterns of Shh and Hh target genes in wild type and orJ
retinas. For this purpose, we have chosen general transcriptional targets
of Hh signaling whose expression is upregulated in response to elevated
levels of Hh signaling, including: Gli1, Ptc1, Ptc2, Hedgehog Interacting
Protein (Hhip), andCyclin D1 (Ccnd1). Since SHHproduction andHh target
geneupregulation are tightly correlated to the central-to-peripheralwave
of RGC differentiation, multiple developmental ages were examined.orJ retinas. (A–I) Solid and dashed lines indicate the extent of acTUBB3 immuno-
th acTUBB3 immunoreactivity and Gli1 expression extend to the peripheral retina.
restricted. Note that acTUBB3-positive cells peripheral to the dashed line in (D) are
ild type retinas are centrally restricted. (J–L) Expression of POU4F2 in the E15.5 orJ
ive cells are RGCs. Ventral is to the left in all panels. Scale bars: 200 μm for (A–I);
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early stage of retinal development at which RGCs have begun to
differentiate in the central retina of wild type mice. We ﬁnd clear
evidence of Hh signaling activity in wild type retinas, in the form of
Gli1 mRNA expression in RPCs. This expression is restricted to the
central retina and stronger on the dorsal side (large arrow, Fig. 1A).
In contrast, we fail to detect Gli1 mRNA in orJ retinas at this age
(Fig. 1B). However, we ﬁnd strong Gli1 expression in extra-retinal
tissue of orJ mice, as in wild type mice, presumably due to extra-
retinal sources of Hh ligands (arrowheads, Figs. 1A,B; Dakubo et al.,
2003).
The Hh target genes Ptc1 and Hhip are also expressed, albeit
weakly, in the central retina of wild type mice, but were not detected
in orJ retinas (Figs. 1C–F). Shh and Ptc2mRNAs were difﬁcult to detect
at this age in both genotypes (not shown). Since Vsx2 mRNA is
expressed strongly in the orJ retina, we used it as both a positiveFig. 4. SHH-N treatment promotes proliferation in embryonic organotypic retinal explant cult
of SHH-N for 24 h with BrdU added for the last 30 min. (A, D) BrdU incorporation. (B, E) PCNA
the dashed lines. Scale bar: 100 μm. (G) Quantiﬁcation of BrdU+ cells as a function of retinal a
calculated using Student's paired t-test.control for the orJ retinal tissue and a marker of RPCs (Figs. 1G,H).
Open arrowheads in Fig. 1H point to reduced Vsx2 expression in the
extreme retinal periphery (see below). Taken together, our data
indicate Hh signaling is aberrantly absent during this early period of
retinal development in orJ mice.
We next examined gene expression patterns at E15.5, a stage of
retinal development at which the wave of RGC differentiation has
reached the peripheral retina in wild type mice. In situ hybridiza-
tion reveals Shh expression in the nascent RGC layer, extending to
the peripheral retina of wild type mice (arrows, Fig. 2A). However,
Shh expression is only observed in the central retina of orJ mice at
this age (arrows, Fig. 2B). We also observed a corresponding
restriction of Hh target gene expression territories. In wild type
mice, expression of the Hh target genes Gli1 and Ptc1 in RPCs
extends to the peripheral retina (Figs. 2C,E), similar to the extent of
Shh expression. In orJ retinas, however, expression of Gli1 and Ptc1ures from orJmice. E12.5 explants were cultured in the absence (A–C) or presence (D–F)
immunoreactivity. (C, F) acTUBB3 immunoreactivity. Retinal tissue is contained within
rea (mm2). Each bar represents the mean±standard error of the mean (S.E.M.). p-values
566 C.L. Sigulinsky et al. / Developmental Biology 317 (2008) 560–575is centrally restricted (Figs. 2D,F). Ptc2 expression was again
difﬁcult to detect in wild type and orJ retinas at this age (data
not shown). These gene expression patterns indicate that in orJFig. 5. Expression patterns of Hh target genes at P0. In situ hybridization for the Hh target g
retinas at P0. (E(*), F(*)) Ptc2mRNA expression is undetectable in either genotype. (G(*), H(*)) H
hybridization for Vsx2 mRNA serves as a control. Scale bars: 250 μm (A–J); 40 μm (A*–J*). Nmice, unlike wild type mice of the same age, Hh signaling is absent
in the peripheral E15.5 retina. In situ hybridization for Vsx2 mRNA
(Figs. 2I,J) shows that the absence of peripheral Hh target geneenes Gli1 (A(*), B(*)) and Ptc1 (C(*), D(*)) reveals reduced expression for both genes in orJ
hip transcript is expressed in wild type retinas, but absent in orJ retinas. (I(*), J(*)) In situ
BL, neuroblast layer; DCL, differentiated cell layer.
Fig. 6. Quantiﬁcation of relative expression levels for Hh network components in P0 wild type and orJ retinas by sqRT-PCR. The meanwild type expression level for each genewas set
at 100% with the orJ level presented as a percent of wild type expression. Hh target genes are those genes whose expression levels are generally considered as indicators of pathway
activity. Bars represent the mean±standard deviation. n refers to the number of independently isolated RNA samples. p-values calculated by Student's unpaired t-test or Welch's two
sample t-test, as appropriate (based on results of an F test of variances). See Supplemental Fig. S1 for sqRT-PCR optimization curves.
Fig. 7. Shh expression at P0. (A) Relative expression levels of Shh and Pou4f2 mRNAs in wild type and orJ retinas as determined by sqRT-PCR. Bars represent the mean±standard
deviation. n and p-values are deﬁned as described in Fig. 6. (B) Relative expression of SHH protein in wild type and orJ retinal protein lysates. Closed arrowhead points to band
consistent with size of full-length SHH and open arrowhead points to band consistent with size of the N-terminal fragment of SHH. Blot was reprobed to show ACTB expression as an
independent measure for protein loading. (C–F) Spatial expression of SHH protein inwild type and orJ eyes. Scale bars: 200 μm for (C, D); 50 μm for (E, F). See Supplemental Fig. S2 for
anti-SHH immunoreactivity controls.
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exception of the extreme retinal periphery, where a reduction of
Vsx2 expression is correlated with a propensity toward transdiffer-
entiation (open arrowheads in Figs. 1H and 2J; Horsford et al.,
2005; Rowan et al., 2004). Interestingly, these centrally restricted
expression territories for Shh and the Hh target genes are remi-
niscent of those observed for wild type retinas at earlier stages of
development (Fig. 1; Dakubo et al., 2003; Wang et al., 2005). Taken
together with the E12.5 expression patterns, these ﬁndings suggest a
delay, both in the expression of Shh and activation of Hh signaling.
Consistent with this, Gli1mRNA and SHH protein expression extend to
the peripheral retina in orJ animals by P0 (Figs. 5 and 7).
While Gli1 and Ptc1 exhibit altered expression territories in the orJ
retina, their levels appear normal where expressed (Figs. 2D,F
compared to C,E). This indicates that even in the absence of Vsx2,
RPCs retain some ability to respond to SHH ligand. However, the
expression of another Hh target gene, Hhip, suggests that the response
of RPCs to SHH is altered to some extent, even in the central retina of
orJ mice. While the pattern of Hhip expression is comparable to those
of Gli1 and Ptc1 in the wild type retina, HhipmRNA is undetectable in
orJ retinas (Figs. 2G,H).
The delay in Hh signaling activity correlates with delayed RGC
production
Since RPCs have been shown to only respond to RGC-derived SHH
in the mouse (Dakubo et al., 2003; and our data) and RGC
differentiation is delayed in the orJ retina (Bone-Larson et al., 2000),
we sought to determine if Hh signaling activity in the orJ retina
correlates with the extent to which the peripherally-spreading wave
of RGC differentiation has progressed.
To begin to address this question, retinal sections were
examined for Gli1 mRNA expression by in situ hybridization and
acetylated class III beta-Tubulin (acTUBB3) by immunohistochem-
istry on the same sections. Gli1 expression is an indicator of active
Hh signaling and acTUBB3 serves as a marker of postmitotic
neurons. While acTUBB3+ cells and Gli1 expression extend to the
peripheral retina of wild type mice at E15.5 (Figs. 3A–C), orJ retinas
at this age exhibit a centrally restricted domain of acTUBB3+ cells
(Figs. 3D–F), consistent with delayed neurogenesis in the orJ retina
(note: acTUBB3+ cells more peripheral than the solid lines are
located within the vitreal space, not the neural retina). Despite this
delay, the spatial boundary of Gli1 expression in the orJ retina
aligns with, or is slightly more centrally restricted than, the
boundary for acTUBB3 immunoreactivity (Figs. 3E,F). These expres-
sion patterns are similar to what is observed in the E12.5 wild type
retina (Figs. 3G–I), a stage where the initial wave of neurogenesis is
still in the process of progressing towards the periphery. We also
found that many of the acTUBB3+ cells also expressed POU4F2
(formerly BRN3B), a marker of a major subset of RGCs (Figs. 3J–L).
These data indicate that the relationship between activation of the
Hh signaling network and RGC differentiation shown for normal
retinal development (Wang et al., 2005) is maintained in the orJ
retina.
To address this further, we sought to determine whether orJ
RPCs are competent to respond to SHH ligand prior to the onset
of neurogenesis and the appearance of endogenous RGC-derived
SHH. To test this, organotypic retinal explants from E12.5
orJ mice were maintained in the presence or absence of recom-
binant, N-terminal SHH protein (SHH-N) for 24 h and examinedFig. 8. SHH-N treatment promotes proliferation in neonatal explants within 24 h. BrdU (A,
culture. Quantiﬁcation of BrdU+ (G), pHH3+ (H), and PCNA+ (I) cells inwild type explants as a f
pHH3 (K, N), and PCNA (L, O) immunoreactivity in orJ explants after 24 h in culture. Quantiﬁc
retinal area (P, R) and length of the apical surface of the retina (Q). Bars represent mean±S.for proliferation and neurogenesis. Proliferation was assessed
by BrdU incorporation and neurogenesis was assessed by ac-
TUBB3 immunoreactivity. PCNA was used to assess the relative
size of the RPC population since it is a comprehensive marker
of RPCs (Barton and Levine, 2008). We found that orJ RPCs ex-
hibited a signiﬁcant increase in BrdU+ cells in response to SHH-N
treatment without any apparent changes in the proportion
of PCNA+ or acTUBB3+ cells (Fig. 4). These observations indicate
that naive orJ RPCs are able to increase proliferation in response
to SHH ligand and that SHH-N is acting directly on the RPCs
as neurogenesis was not initiated. In sum, our data indicate that
the delay in Hh signaling activity negatively impacts prolifera-
tion and the delay is primarily the consequence of limited SHH
production due to the delay of RGC differentiation in the em-
bryonic orJ retina.
Shh signaling is altered in the orJ retina at birth despite the presence of
SHH ligand
Reduced proliferation persists in the orJ retina at perinatal ages
(Dhomen et al., 2006; Green et al., 2003; Livne-Bar et al., 2006). We
therefore wished to determine if Hh signaling is altered at P0. To do
this, we examined the expression patterns of Hh target genes by in
situ hybridization and determined their relative expression levels by
sqRT-PCR.
In situ hybridization shows that Gli1 mRNA is abundantly
expressed in RPCs of wild type P0 retinas (Fig. 5A(*)). However, in
the orJ retina, Gli1 expression is reduced, patchy and more variable
(Fig. 5B(*)). Ptc1 is expressed in the wild type retina, but appears
reduced in the orJ retina (Fig. 5C(*),D(*)). Ptc2 mRNA was undetect-
able in both cases (Fig. 5E(*),F(*)). As at the earlier ages, Hhip
expression is obvious in the wild type retina but undetectable in the
orJ retina (Figs. 5G(*),H(*)). In situ hybridization for Vsx2 mRNA (Figs.
5I(*),J(*)) serves as a control and reveals strong expression, regardless
of genotype.
To determine the relative expression levels of the Hh target genes,
we performed sqRT-PCR on equivalent amounts of total RNA from P0
wild type and orJ retinas (Fig. 6). The relative expression levels of Gli1,
Ptc2, Hhip, and Ccnd1 were signiﬁcantly lower in the orJ retina
compared to wild type. Ptc1 was the only target gene that did not
show a signiﬁcant change in expression level.
We also examined the expression of Smo, Gli2, and Gli3,
essential components of the signaling pathway (Fig. 6; Supple-
mental Fig. S1). Only Gli3 was signiﬁcantly downregulated in the
orJ retina, although Gli2 exhibited a similar trend. These observa-
tions demonstrate that Hh signaling, as measured by the level of
target gene expression, is reduced in the newborn orJ retina, and at
least one component of the cell-intrinsic portion of the pathway,
Gli3, is signiﬁcantly reduced.
In addition to Hh target genes and important signaling
components, we assessed the production and availability of SHH
in the retina at P0. We determined the relative levels of Shh mRNA
expression by sqRT-PCR and found that its expression is reduced in
the newborn orJ retina (Fig. 7A). Pou4f2, which is believed to
regulate Shh expression in RGCs (Mu et al., 2004), is expressed at
levels that are not signiﬁcantly different from wild type (Fig. 7A).
Western blots show strong SHH expression in the orJ retinas,
although it may be expressed at reduced levels compared to wild
type (Fig. 7B; Supplemental Fig. S2). Immunohistochemistry reveals
that SHH protein is localized to the nascent RGC layer, withD), pHH3 (B, E), and PCNA (C, F) immunoreactivity in wild type explants after 24 h in
unction of retinal area (G, I) and length of the apical surface of the retina (H). BrdU (J, M),
ation of BrdU+ (P), pHH3+ (Q), and PCNA+ (R) cells in wild type explants as a function of
E.M. p-values calculated using Student's paired t-test. Scale bar: 50 μm.
Fig. 9. CCND1 expression in retinal explants after 8 h of culture. Western blot of total
retinal protein isolated from retinal explants cultured in the presence (+) or absence (−)
of SHH-N and probed with anti-CCND1. Blot was reprobed with anti-ACTB.
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mental Fig. S2). Together, these experiments show that SHH ligand
is expressed in the newborn orJ retina in a manner similar to wildFig. 10. SHH-N treatment stimulates expression of Hh target genes in explant culture. Relativ
points are relative to the wild type expression level at 0 h (set at 100%). 0 h is deﬁned as is
genotype at 0 h is referred to in the text as the baseline expression level. Data points repretype, although the RT-PCR and western blot data indicate a reduced
level of expression.
Neonatal orJ RPCs respond to exogenous and endogenous SHH in explant
cultures
To determine if neonatal orJ RPCs are able to respond to
exogenous SHH, we treated P0 retinal explants with SHH-N for 24 h
and assayed for proliferation. We observed signiﬁcant increases in
BrdU+ and pHH3+ cells in SHH-N treated explants compared to
untreated explants from both wild type (Figs. 8A,B,D,E,G,H;
Supplemental Table 1) and orJ mice (Figs. 8J,K,M,N,P,Q; Supple-
mental Table 2). Similarly, western blot analyses revealed that an
8 h exposure of SHH-N was also sufﬁcient to increase CCND1
protein levels, regardless of genotype (Fig. 9). These observations
demonstrate that despite evidence of attenuated endogenous Hh
signaling in vivo, orJ RPCs can increase proliferation in response to
exogenous SHH. Interestingly, the relative proportion of PCNA+ cells
did not change in either genotype (Figs. 8C,F,I,L,O.R; Supplemental
Tables 1 and 2), suggesting that SHH-N stimulates cell cyclee expression levels of Hh target genes from retinal explants after 8 h in culture. All data
olated retinal tissue frozen immediately after dissection. The expression level for each
sent the mean±standard deviation. p-values are provided in Tables 1 and 2.
Table 1
Expression level changes due to SHH-N treatment at 8 h transcript
Transcript Genotype Mean difference±S.D.a p-valueb
Ccnd1 Wild type 249.75±279.59 0.172
orJ 1058.07±302.72 0.006
Gli1 Wild type 1876.94±447.19 0.003
orJ 2593.01±691.73 0.005
Ptc1 Wild type 412.62±222.30 0.034
orJ 994.47±1215.65 0.20
Ptc2 Wild type 780.06±115.85 0.001
orJ 918.50±239.46 0.005
Hhip Wild type 876.37±208.11 0.003
orJ 1435.12±187.14 0.0006
a Mean is calculated for the differences in pixel area measurements of ethidium bro-
mide stained PCR products run through agarose for SHH-N treated versus untreated
explants of each genotype. Samples are paired (n=4).
b p-values calculated by paired Student's t-test.
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(see Discussion).
To assess whether the SHH-N mediated proliferative response
correlated with stimulation of the Hh signaling pathway, we
examined the expression of Hh target genes after culturing P0
retinal explants in the presence or absence of SHH-N for 8 h by sqRT-
PCR (Fig. 10; Tables 1 and 2). Regardless of genotype, we observed
that SHH-N treatment generally resulted in elevated expression
levels of Hh target genes when compared to untreated explants
(Fig. 10; Table 1). When compared to the baseline expression levels
(t=0), however, wild type and orJ explants exhibited different
behaviors. In wild type explants, SHH-N treatment did not cause
gene expression levels to increase in a signiﬁcant manner over
baseline levels, whereas in explants not exposed to SHH-N, gene
expression levels declined (Fig. 10; Table 2). In contrast, orJ explants
treated with SHH-N showed elevated gene expression whereas
untreated explants showed little change in expression when
compared to baseline levels (Fig. 10; Table 2). In sum, these
observations show that SHH-N stimulates the Hh signaling pathway
in the orJ retina, although the modulations of target gene expression
differ between genotypes.
While these explant experiments revealed that orJ RPCs are
able to respond to exogenous ligand, it remains that Hh target
gene expression is substantially reduced in vivo even though
endogenous ligand is expressed. Thus, we sought to conﬁrm that
orJ RPCs are in fact responding to the endogenous, RGC-derived
SHH ligand in vivo by performing two independent analyses. First,
we directly compared the P0 patterns of Gli1 mRNA and acTUBB3
on the same retinal sections. As at E15.5 we found the highestTable 2
Relative expression levels at baseline (t=0 h) and 8 h in culture
Transcript Genotype Baselinea −SHH-Na
Ccnd1 Wild type 100±2.70 99.58±5.
orJ 62.40±3.50 72.49±10
Gli1 Wild type 100±8.36 52.24±10
orJ 66.75±8.71 47.60±11
Ptc1 Wild type 100±8.99 87.32±9.
orJ 87.91±6.11 99.40±5.
Ptc2 Wild type 100±30.30 37.26±7.
orJ 65.15±10.66 38.74±10
Hhip Wild type 100±4.45 53.74±10
orJ 18.14±4.88 10.95±3.
a For each transcript, values±S.D. are normalized to the wild type baseline measurement
b Unpaired Student's t-tests were done to determine if the values derived from samples t
statistical comparison, the 8 h measurements were compared to the baseline value of the s
c p-value for comparison between baseline and −SHH-N.
d p-value for comparison between baseline and +SHH-N.levels of Gli1 expression adjacent to acTUBB3-positive cells in both
wild type and orJ retinas (data not shown), which is consistent
with the idea that signaling is most robust near the cells that
produce the ligand. Second, we performed explant cultures of P0
orJ retinas in the presence or absence of cyclopamine, a
pharmacological inhibitor of Hh signaling (Chen et al., 2002;
Cooper et al., 1998; Frank-Kamenetsky et al., 2002; Incardona et al.,
1998; Taipale et al., 2000). After a 16 h culture period, we found
Gli1 expression was reduced in response to cyclopamine treatment
(Figs. 11A,C), while Vsx2 expression remained unchanged (Figs. 11B,
D). Thus, endogenous Hh signaling activity in the orJ retina is
sufﬁcient to promote some level of Hh target gene expression.
Furthermore, cyclopamine-treated explants exhibited a reduction
in proliferation as indicated by signiﬁcant reductions in the
numbers of BrdU+, pHH3+, and PCNA+ cells as compared to
explants treated with vehicle alone (Figs. 11E–M; Supplemental
Table 3). These data indicate orJ RPCs are responding to
endogenous, RGC-derived SHH, at the levels of target gene
expression and proliferation.
Discussion
In this study, we have elucidated some key elements in the
relationship between Vsx2 and Shh in promoting RPC proliferation in
the developing retina. At early embryonic stages, a delay in Hh
signaling in the orJ retina correlates with a delay in RGC development.
At birth, SHH ligand is produced by RGCs and RPCs respond to it, but
Hh signaling in the orJ retina occurs at a reduced level compared to
wild type. Our observations lead us to propose that Vsx2 has
important roles in ensuring the correct timing and magnitude of Hh
signaling in the retina, which ultimately contributes to proper
execution of the histogenetic program.
Retinal Hh target genes
Our analyses of Hh target gene expression in the mouse retina
have revealed several features of their expression and regulation in
this tissue. We have presented the ﬁrst documented expression of
Hhip in the retina, as well as information regarding its transcriptional
regulation in RPCs in response to SHH, thereby revealing its
usefulness as an indicator of Hh signaling activity in the mouse
retina. Gli1, Ptc2, and Hhip are all highly responsive Hh target genes
in the retina. High levels of their expression are dependent upon
active Hh signaling, as evidenced by the large expression difference
between SHH-N treated and untreated explants within a short
culture period. Although Ptc1 expression is a useful indicator of Hh
signaling activity in other systems, we found Ptc1 to be relativelyp-valueb,c +SHH-Na p-valueb,d
03 0.89 103.50±6.06 0.33
.50 0.12 89.11±6.14 0.0003
.99 0.0004 105.84±9.25 0.38
.55 0.038 121.65±11.93 0.0003
92 0.11 95.41±8.97 0.50
69 0.033 118.89±20.84 0.029
85 0.007 133.53±21.99 0.12
.30 0.012 152.10±19.57 0.0002
.90 0.0002 90.52±13.88 0.24
49 0.053 71.17±9.73 6.7e−05
set at 100 (n=4). Values in −SHH-N and +SHH-N are after 8 hr in culture.
aken after 8 h in culture are statistically. Signiﬁcant from the baseline values. For each
ame genotype (pb0.05 reveals a statistically signiﬁcant difference).
Fig. 11. Endogenous SHH promotes proliferation in P0 orJ retinas. orJ retinal explants were cultured in vehicle alone (0.41% v/v DMSO) or 10 μM cyclopamine (in 0.41% v/v DMSO) for
16 h (A–D) or 24 h (E–J). (A, C) Gli1 mRNA expression. (B, D) Vsx2 mRNA expression. BrdU (E, H), pHH3 (F, I), and PCNA (G, J) immunoreactivity. Closed arrowheads in (F, I) indicate
pHH3+ cells at the apical surface of the retina. Quantiﬁcation of BrdU+ (K), pHH3+ (L), and PCNA+ (M) cells as a function of retinal area (K, M) and length of the apical surface of the
retina (L). Bars represent mean±S.E.M. p-values calculated using the Student's paired t-test. Scale bar: 120 μm (A–D), 50 μm (E–J).
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Ptc1 exhibits little to no change in expression after explant culturing
in the presence or absence of SHH-N. Furthermore, while reduced
expression of the other analyzed Hh target genes indicates reduced
Hh signaling in the orJ retina, Ptc1 expression is not signiﬁcantly
different across genotypes. Our ﬁndings are consistent with observa-
tions made in other retinal explant cultures (Wang et al., 2002) and
in the Pou4f2−/− retina, which exhibits reduced Shh expression (Mu et
al., 2004).
The delays in Shh expression and Hh signaling activity in the orJ retina
are a consequence of delayed RGC differentiation during embryonic
development
Our gene expression studies of components of the Hh signaling
network revealed drastically altered mRNA expression territories for
Shh and the Hh target genes Gli1, Ptc1, and Hhip in the orJ retina
during embryonic stages. The lack of expression at E12.5 and centrally
restricted expression patterns observed in orJ retinas at E15.5 are
reminiscent of the wild type expression patterns observed for earlier
ages (our data; Dakubo et al., 2003; Wang et al., 2005). However, at
birth, the expression territories (most notably SHH and Gli1) extend to
the peripheral retina, similar to wild type. Based on these observa-
tions, we conclude that the central-to-peripheral wave of Shh
expression and Hh signaling still occurs in the orJ retina, but is
delayed.
RGC differentiation is also delayed in the orJ retina (Bone-Larson et
al., 2000), and our data are consistent with central-to-peripheral
waves of Shh and Hh target gene expression following a peripherally-
spreading wave of RGC differentiation (Wang et al., 2005). It appears
then, that the relationship between Hh signaling and RGC differentia-
tion is maintained in the orJ retina. Thus, the limited spatial extent of
Hh signaling activity during embryonic retinal development may be
due, in large part, to the altered availability of SHH ligand, owing to a
developmental delay in its cellular source, the RGCs.
Extra-retinal sources of Hh ligands, such as Ihh (Dakubo et al.,
2003; Levine et al., 1997), are expressed during the early embryonic
period, and the high level of Gli1 expression in the periocular
mesenchyme of the orJ mouse suggests they are still present. Even
so, they do not activate Hh signaling in the retina. This is consistent
with previous ﬁndings that the only source of Hh ligand towhich RPCs
respond is RGC-derived Shh (Dakubo et al., 2003).
This delay in RGC differentiation limits the exposure of RPCs to
SHH, which could contribute to the proliferation deﬁciency character-
istic of orJ RPCs, since proliferation is an established response of RPCs
to Hh signaling. Consistent with this idea is our ﬁnding that naïve orJ
RPCs are competent to respond to stimulation of the Hh pathway.
Additionally, mouse models in which RGCs either fail to mature
(Brown et al., 2001; Le et al., 2006; Mu et al., 2004), are ablated with
toxin (Mu et al., 2005), or do not express Shh (Wang et al., 2005, 2002)
exhibit decreased RPC proliferation. The sum of these observations
supports a model in which the proliferative expansion of the
embryonic retina is mechanistically dependent on the production of
RGCs (Mu et al., 2005) and perhaps more generally, on the production
of postmitotic cells. The delay in RGC differentiation in the orJ retina
may also limit the availability of other mitogens, such as GDF8/
myostatin (Mu et al., 2004) and VEGF (Hashimoto et al., 2006; Yang
and Cepko, 1996). How Vsx2 contributes to the correct timing for the
onset of RGC production is not known.
Reduced Hh signaling and proliferative expansion in the neonatal orJ
retina
In addition to the changes observed in the embryonic retina, our
analysis of several Hh target genes reveals that Hh signaling remains
reduced in the neonatal orJ retina, even though signaling is activatedby E15.5 and extends out to the peripheral retina by birth. Since the
proportions of the wild type and orJ RPC populations relative to their
total cell populations do not differ at P0 (Green et al., 2003), the
reductions in Hh target gene expression in the orJ retina are likely due
to changes in gene regulation rather than to changes in cell
composition. This conclusion is supported by our observation that
SHH-N treatment signiﬁcantly enhances Hh target gene expression
within 8 h.
How might Hh signaling inﬂuence orJ RPCs? Our explant experi-
ments indicate that the role of Hh signaling is complex. SHH-N
treatment increased the relative proportions of cells in S andM phases
(as measured by BrdU and pHH3 immunoreactivity) without inﬂuen-
cing the relative proportion of RPCs as indicated by PCNA immunor-
eactivity (Barton and Levine, 2008). These observations suggest that
the primary inﬂuence of SHH-N is to shorten the time orJ RPCs spend
in G1 and/or G2.While cyclopamine treatment had the opposite effect
on the relative proportions of BrdU+ and pHH3+ cells, it also caused a
reduction in the orJ RPC population as inferred by the decrease in
PCNA+ cells. In this case, the reduced proliferation could be due to
prolongation of the G1 and/or G2 phases in addition to enhanced cell
cycle exit. Taken together, it appears then, that a high level of Hh
signaling primarily inﬂuences cell cycle progression in orJ RPCs
whereas a low level of Hh signaling may help to maintain the orJ RPC
population. Consistent with these ideas are the ﬁndings that the orJ
RPC population is at the correct proportion at birth (Green et al., 2003;
unpublished observations), that the cell cycle time of orJ RPCs is
longer than wild type and is primarily due to an increase in G1 time
(Konyukhov and Sazhina, 1971; unpublished observations), and Hh
signaling is active, but at a reduced level in the orJ retina (this paper).
In sum, we propose that Hh signaling is likely a limiting factor for the
proliferative expansion of orJ RPCs. Thus, in addition to any direct
roles Vsx2 has in regulating cell cycle progression and other aspects of
RPC behavior, we propose that reduced signaling in at least one
growth factor pathway also contributes to the proliferation problems
characteristic of the orJ retina.
Hh signaling is tightly controlled at almost every step of the
pathway, from ligand production to activity of the transcriptional
effectors. Changes in any of these processes impact the level of
signaling activity (Cohen, 2003; Ingham, 1998; Ingham and McMa-
hon, 2001; Nybakken and Perrimon, 2002; Varjosalo and Taipale,
2007). Our expression data revealed that the expression of Shh mRNA
and protein are reduced in the orJ retina at P0. Whether these drops
in expression are sufﬁcient to completely account for the level of
reduced signaling is unclear. Interestingly, orJ cells that expressed
SHH appeared to do so in a robust manner. Since processing and
secretion of HH ligands are under complex control and defects in
these mechanisms could also contribute to reduced signaling levels, it
is possible that problems of this nature are further limiting the
exposure of SHH to orJ RPCs. Importantly, alterations in Hh signaling
and proliferation due to reduced expression or to problems in
processing or secretion indicate that non-cell autonomous changes
may contribute to the orJ phenotype since Vsx2 is not expressed in
RGCs.
Although reduced ligand production likely contributes to the di-
minished levels of Hh signaling in the orJ retina, there is also ample
precedence for the involvement of extracellular molecules in
modulating the magnitude of Hh signaling through their inﬂuence
on ligand dispersion and/or reception (Cohen, 2003; Ingham, 1998;
Ingham and McMahon, 2001; Nybakken and Perrimon, 2002;
Varjosalo and Taipale, 2007). In addition to being transcriptional
targets, Hhip and Ptc2 are also extracellular regulators of Hh signaling.
Their reduced expression in the orJ retina, however, is not likely to
account for the changes in Hh signaling levels. Hhip functions as a
negative regulator resulting in attenuated Hh signaling (Chuang et al.,
2003; Chuang and McMahon, 1999). Thus, its expression change is
counter to Hhip being a mechanistic explanation of reduced Hh
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for Hh ligands (Carpenter et al., 1998), it lacks the ability to mediate
SHH-stimulated signaling and inhibits SHH function (Rahnama et al.,
2004). Based on these ﬁndings, Ptc2 also functions as a negative
regulator. Thus, although it appears that reduced Hhip and Ptc2
expression cannot explain the reduced levels of Hh signaling in the orJ
retina, they do provide strong evidence that a change in Hh signaling
is occurring. Gas1, a GPI-anchored membrane protein, is negatively
regulated by Hh signaling (Allen et al., 2007) and is upregulated in the
embryonic orJ retina (Rowan et al., 2004). Whether this elevated
expression is the result of reduced Hh signaling or an unrelated
change caused by the absence of Vsx2 is not known. Additionally,
since Gas1 can act as a positive (Allen et al., 2007; Lee et al., 2001b; Liu
et al., 2002, 2001) or negative (Cobourne et al., 2004; Lee et al., 2001a)
regulator of Hh signaling, it is difﬁcult to predict the consequences of
its change in expression.
Changes in the intracellular portion of the pathway could also alter
Hh signaling, but whether these types of changes are causal factors for
reduced signaling and proliferation is unclear. We found that
cyclopamine treatment further reduced Gli1 expression and prolifera-
tion, and SHH-N treatment stimulated target gene expression and
proliferation. While these ﬁndings demonstrate that the intracellular
portion of the Hh pathway is functional in the orJ retina, we cannot
conclude that the response observed in the orJ explants is equivalent
to a ‘wild type response’. This is because the behaviors of orJ and wild
type explants are qualitatively different. Wild type explants treated
with SHH-N exhibit maintenance of their baseline expression levels
for most target genes, indicating that wild type RPCs are responding
maximally. Furthermore, target gene expression in wild type explants
not exposed to SHH-N drop below baseline levels, indicating that
continuous exposure to ligand is necessary to sustain expression
levels. In contrast, orJ explants exposed to SHH-N show stimulation
above baseline levels and most target genes do not drop below
baseline levels in untreated explants. Furthermore, since the baseline
levels of Hh regulators and cell intrinsic effectors differ in the orJ
retina compared to wild type (e.g. Gli1, Ptc2, Hhip, Gli3), a direct
comparison of the quality of response to SHH-N between the orJ and
wild type RPCs is not easily accomplished. Thus, while our data shows
that the intrinsic portion of the Hh pathway is functioning in orJ RPCs,
it is possible that alterations in this part of the pathway are also
causing changes in RPC behavior.
In sum, our data provide evidence for a model in which Vsx2
promotes RPC proliferation in a non-cell autonomous manner by
ensuring proper RGC differentiation and Hh signaling during em-
bryonic retinal development, which is in addition to its cell auto-
nomous functions in RPCs. Furthermore, we propose that Hh signaling
is a limiting factor for RPC proliferation in the absence of Vsx2. While
Shh expression is reduced in the orJ retina, the loss of Vsx2 may also
impact the Hh pathway downstream of ligand expression, by altering
the expression of components of the Hh signaling network, or by
maintaining an environment inwhich RPCs can respond appropriately
to SHH ligand. While more work is needed to identify the molecular
mechanisms by which Vsx2 regulates RPC proliferation, our work
highlights the complex interactions between the tissue-restricted cell-
intrinsic factor Vsx2 and Hh signaling, in their contributions to the
proliferative expansion of cell number during retinal histogenesis.
Acknowledgments
We thank Dr. Henk Roelink, University of Washington, for SHH-N
protein and Dr. Valerie Wallace, Ottawa Health Research Institute,
Canada, for Hh network-related plasmids. We also thank Drs. Sabine
Fuhrmann, Scott Kuwada, Henk Roelink, and Sen Wu for advice
regarding antibodies.
We thank Drs. Sabine Fuhrmann, Henk Roelink, and Tom Reh for
critical reading of the manuscript and members of the Fuhrmann andLevine laboratories, especially Todd Raleigh and Amy Kircher, for their
insights and assistance.
Funding Support: Career Development Award to E.M.L. from
Research to Prevent Blindness, Inc., Foundation Fighting Blindness,
and the National Eye Institute (EY013760); NEI Vision Core Grant
(EY0014800); Ruth Kirchstein NRSA from the NEI to E.S.G.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ydbio.2008.02.055.
References
Allen, B.L., et al., 2007. The Hedgehog-binding proteins Gas1 and Cdo cooperate to
positively regulate Shh signaling during mouse development. Genes Dev. 21,
1244–1257.
Barton, K.M., Levine, E.M., 2008. Expression patterns and cell cycle proﬁles of PCNA,
MCM6, Cyclin D1, Cyclin A2, Cyclin B1, and phosphorylated Histone H3 in the
developing mouse retina. Dev. Dyn. 237, 672–682.
Bar-Yosef, U., et al., 2004. CHX10 mutations cause non-syndromic micro-
phthalmia/anophthalmia in Arab and Jewish kindreds. Hum. Genet. 115,
302–309.
Belecky-Adams, T., et al., 1997. Pax-6, Prox 1, and Chx10 homeobox gene expression
correlates with phenotypic fate of retinal precursor cells. Invest. Ophthalmol. Vis.
Sci. 38, 1293–1303.
Bone-Larson, C., et al., 2000. Partial rescue of the ocular retardation phenotype by
genetic modiﬁers. J. Neurobiol. 42, 232–247.
Brown, N.L., et al., 2001. Math5 is required for retinal ganglion cell and optic nerve
formation. Development 128, 2497–2508.
Burmeister, M., et al., 1996. Ocular retardation mouse caused by Chx10 homeobox null
allele: impaired retinal progenitor proliferation and bipolar cell differentiation. Nat.
Genet. 12, 376–384.
Carpenter, D., et al., 1998. Characterization of two patched receptors for the vertebrate
hedgehog protein family. Proc. Natl. Acad. Sci. U. S. A. 95, 13630–13634.
Chen, J.K., et al., 2002. Inhibition of Hedgehog signaling by direct binding of
cyclopamine to Smoothened. Genes Dev. 16, 2743–2748.
Chuang, P.T., McMahon, A.P., 1999. Vertebrate Hedgehog signalling modulated by
induction of a Hedgehog-binding protein. Nature 397, 617–621.
Chuang, P.T., et al., 2003. Feedback control of mammalian Hedgehog signaling by the
Hedgehog-binding protein, Hip1, modulates Fgf signaling during branching
morphogenesis of the lung. Genes Dev. 17, 342–347.
Clark, A.M., et al., 2008. Negative regulation of Vsx1 by its paralog Chx10/Vsx2 is
conserved in the vertebrate retina. Brain Res. 1192, 99–113.
Cobourne, M.T., et al., 2004. Restriction of sonic hedgehog signalling during early tooth
development. Development 131, 2875–2885.
Cohen Jr., M.M., 2003. The hedgehog signaling network. Am. J. Med. Genet. A 123, 5–28.
Cooper, M.K., et al., 1998. Teratogen-mediated inhibition of target tissue response to Shh
signaling. Science 280, 1603–1607.
Dakubo, G.D., Wallace, V.A., 2004. Hedgehogs and retinal ganglion cells: organizers of
the mammalian retina. NeuroReport 15, 479–482.
Dakubo, G.D., et al., 2003. Retinal ganglion cell-derived sonic hedgehog signaling is
required for optic disc and stalk neuroepithelial cell development. Development
130, 2967–2980.
Del Bene, F., Wittbrodt, J., 2005. Cell cycle control by homeobox genes in development
and disease. Semin. Cell Dev. Biol. 16, 449–460.
Dhomen, N.S., et al., 2006. Absence of chx10 causes neural progenitors to persist in the
adult retina. Invest. Ophthalmol. Vis. Sci. 47, 386–396.
Donovan, S.L., Dyer, M.A., 2005. Regulation of proliferation during central nervous
system development. Semin. Cell Dev. Biol. 16, 407–421.
Dorval, K.M., et al., 2006. CHX10 targets a subset of photoreceptor genes. J. Biol. Chem.
281, 744–751.
Ferda Percin, E., et al., 2000. Human microphthalmia associated with mutations in the
retinal homeobox gene CHX10. Nat. Genet. 25, 397–401.
Frank-Kamenetsky, M., et al., 2002. Small-molecule modulators of Hedgehog signaling:
identiﬁcation and characterization of Smoothened agonists and antagonists. J. Biol.
1, 10.
Green, E.S., et al., 2003. Genetic rescue of cell number in a mouse model of
microphthalmia: interactions between Chx10 and G1-phase cell cycle regulators.
Development 130, 539–552.
Hashimoto, T., et al., 2006. VEGF activates divergent intracellular signaling components
to regulate retinal progenitor cell proliferation and neuronal differentiation.
Development 133, 2201–2210.
Hatakeyama, J., et al., 2001. Roles of homeobox and bHLH genes in speciﬁcation of a
retinal cell type. Development 128, 1313–1322.
Ho, K.S., Scott, M.P., 2002. Sonic hedgehog in the nervous system: functions,
modiﬁcations and mechanisms. Curr. Opin. Neurobiol. 12, 57–63.
Horsford, D.J., et al., 2005. Chx10 repression of Mitf is required for the maintenance of
mammalian neuroretinal identity. Development 132, 177–187.
Incardona, J.P., et al., 1998. The teratogenic Veratrum alkaloid cyclopamine inhibits sonic
hedgehog signal transduction. Development 125, 3553–3562.
Ingham, P.W., 1998. Transducing Hedgehog: the story so far. EMBO J. 17, 3505–3511.
575C.L. Sigulinsky et al. / Developmental Biology 317 (2008) 560–575Ingham, P.W., McMahon, A.P., 2001. Hedgehog signaling in animal development:
paradigms and principles. Genes Dev. 15, 3059–3087.
Jensen, A.M., Wallace, V.A., 1997. Expression of Sonic hedgehog and its putative role as a
precursor cell mitogen in the developing mouse retina. Development 124, 363–371.
Konyukhov, B.V., Sazhina, M.V., 1971. Genetic control over the duration of G 1 phase.
Experientia 27, 970–971.
Le, T.T., et al., 2006. Math5 is required for both early retinal neuron differentiation and
cell cycle progression. Dev. Biol. 295, 764–778.
Lee, C.S., et al., 2001a. Evidence that the WNT-inducible growth arrest-speciﬁc gene 1
encodes an antagonist of sonic hedgehog signaling in the somite. Proc. Natl. Acad.
Sci. U. S. A. 98, 11347–11352.
Lee, C.S., et al., 2001b. Transdifferentiation of the ventral retinal pigmented epithelium
to neural retina in the growth arrest speciﬁc gene 1 mutant. Dev. Biol. 236, 17–29.
Levine, E.M., Green, E.S., 2004. Cell-intrinsic regulators of proliferation in vertebrate
retinal progenitors. Semin. Cell Dev. Biol. 15, 63–74.
Levine, E.M., et al., 1997. Sonic hedgehog promotes rod photoreceptor differentiation in
mammalian retinal cells in vitro. J. Neurosci. 17, 6277–6288.
Liu, Y., et al., 2001. Growth arrest speciﬁc gene 1 is a positive growth regulator for the
cerebellum. Dev. Biol. 236, 30–45.
Liu, Y., et al., 2002. Growth arrest speciﬁc gene 1 acts as a region-speciﬁc mediator of the
Fgf10/Fgf8 regulatory loop in the limb. Development 129, 5289–5300.
Livesey, F.J., Cepko, C.L., 2001. Vertebrate neural cell-fate determination: lessons from
the retina. Nat. Rev., Neurosci. 2, 109–118.
Livne-Bar, I., et al., 2006. Chx10 is required to block photoreceptor differentiation but is
dispensable for progenitor proliferation in the postnatal retina. Proc. Natl. Acad. Sci.
U. S. A. 103, 4988–4993.
Locker, M., et al., 2006. Hedgehog signaling and the retina: insights into the mechanisms
controlling theproliferativepropertiesof neural precursors. GenesDev. 20, 3036–3048.
Moshiri, A., Reh, T.A., 2004. Persistent progenitors at the retinal margin of ptc+/−mice. J.
Neurosci. 24, 229–237.
Mu, X., et al., 2004. Discrete gene sets depend on POU domain transcription factor
Brn3b/Brn-3.2/POU4f2 for their expression in the mouse embryonic retina.
Development 131, 1197–1210.
Mu, X., et al., 2005. Ganglion cells are required for normal progenitor-cell proliferation
but not cell-fate determination or patterning in the developing mouse retina. Curr.
Biol. 15, 525–530.Nybakken, K., Perrimon, N., 2002. Hedgehog signal transduction: recent ﬁndings. Curr.
Opin. Genet. Dev. 12, 503–511.
Oliver, T.G., et al., 2003. Transcriptional proﬁling of the Sonic hedgehog response: a
critical role for N-myc in proliferation of neuronal precursors. Proc. Natl. Acad. Sci.
U. S. A. 100, 7331–7336.
Rahnama, F., et al., 2004. Distinct roles of PTCH2 splice variants in Hedgehog signalling.
Biochem. J. 378, 325–334.
Rowan, S., Cepko, C.L., 2004. Genetic analysis of the homeodomain transcription factor
Chx10 in the retina using a novel multifunctional BAC transgenic mouse reporter.
Dev. Biol. 271, 388–402.
Rowan, S., et al., 2004. Transdifferentiation of the retina into pigmented cells in ocular
retardation mice deﬁnes a new function of the homeodomain gene Chx10.
Development 131, 5139–5152.
Rutherford, A.D., et al., 2004. Delayed expression of the Crx gene and photoreceptor
development in the Chx10-deﬁcient retina. Invest. Ophthalmol. Vis. Sci. 45, 375–384.
Schaeren-Wiemers, N., Gerﬁn-Moser, A., 1993. A single protocol to detect transcripts of
various types and expression levels in neural tissue and cultured cells: in situ
hybridization using digoxigenin-labelled cRNA probes. Histochemistry 100, 431–440.
Taipale, J., et al., 2000. Effects of oncogenic mutations in Smoothened and Patched can
be reversed by cyclopamine. Nature 406, 1005–1009.
Toy, J., et al., 2002. Effects of homeobox genes on the differentiation of photoreceptor
and nonphotoreceptor neurons. Invest. Ophthalmol. Vis. Sci. 43, 3522–3529.
Varjosalo, M., Taipale, J., 2007. Hedgehog signaling. J. Cell. Sci. 120, 3–6.
Wallace, V.A., Raff, M.C., 1999. A role for Sonic hedgehog in axon-to-astrocyte signalling
in the rodent optic nerve. Development 126, 2901–2909.
Wang, Y.P., et al., 2002. Development of normal retinal organization depends on Sonic
hedgehog signaling from ganglion cells. Nat. Neurosci. 5, 831–832.
Wang, Y., et al., 2005. Retinal ganglion cell-derived sonic hedgehog locally controls
proliferation and the timing of RGC development in the embryonic mouse retina.
Development 132, 5103–5113.
Yang, X.J., 2004. Roles of cell-extrinsic growth factors in vertebrate eye pattern
formation and retinogenesis. Semin. Cell Dev. Biol. 15, 91–103.
Yang, K., Cepko, C.L., 1996. Flk-1, a receptor for vascular endothelial growth factor
(VEGF), is expressed by retinal progenitor cells. J. Neurosci. 16, 6089–6099.
Young, R.W., 1985. Cell differentiation in the retina of the mouse. Anat. Rec. 212,
199–205.
